My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


SpaceX, Blue Origin Could Get Faster Launch A...
Analyst Says AI Is Making SK Hynix Less Cycli...
Visa Delivers Reassuring Read on the US Consu...
Bitcoin Volume Hits 2023 Lows as Analyst Warn...
Ford CEO Jim Farley Backs USMCA Overhaul, Say...
OpenAI, Anthropic Workers Sound Alarm on AI R...
Meta Pledged 100% Renewable Energy in 2016: 1...
Record Mining Profits Can’t Fix Copper’s Brok...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ACADIA PHARMACEUTICALS INC (NASDAQ: ACAD)

    Overview
    current price
    $26.34
    $26.34
    change
    0.33 | 1.27%
    0.33 | 1.27%
    Yesterday's Close
    26.01
    open
    26.12
    volume
    1.73 M
    30d. avg volume.
    1.71 M
    1 day
    25.82 - 26.54
    52 weeks
    19.69 - 28.35
    p/e
    11.77
    beta
    0.7981
    market cap
    4.45 B
    dividend yield
    0.00%
    Industry
    -
    acad by TradingView
    News and Commentary
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    Neuro Drug Stocks Rise Following Intra-CellularTherapies' Drug Approval One indisputable trend about the modern world is that people are living longer. In 1950, the average lifespan for an American was 68 years old. Today, it's 78. One result of a lo...
    Market Summary: Oil Prices Rise After Saudi Arabia Names New Energy Minister Following lack of major U.S. economic data or earnings reports being released early in the week, much of market focus has been toward overseas data and the global economy. The U....
    StockTwits
    StockTwits
    Most Shared
    AI Making Life More Expensive for You? Federal Reserve Says 'Upward Pressure' Likely to Sustain for Now
    AMD Rises After Microsoft's Helios Win: Is Nvidia Finally Facing Real Competition?
    Netflix Just Knocked the BBC Off Its Throne — Streaming Emerges as Fastest Growing Category: Report
    Most Popular
    Bloom Energy Hit By Explosive Short Report Questioning China-Free Supply Claims
    Nvidia, Meta and 23 Others Put Their Names on Open-Weight AI Letter — Google, Amazon and the Closed Labs Keep Theirs Off
    AMD Stock Drops 5%: Why Global Supply Chain Fears and Tech Profit-Taking Are Hurting Chip Giants
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?